• Tuesday, August 16, 2022

Coronavirus4963 D

India approves late-stage trial of Covid vaccine developed by Sanofi, GSK

INDIAN authorities have given approval for a late-stage clinical trial of a protein-based Covid-19 vaccine candidate developed by Sanofi SA and GlaxoSmithKline Plc, the drugmakers said. France’s Sanofi and Britain’s…